TrkB-Fc (100 ng/mouse), a dose known to suppress allodynia in other chronic pain models35, effectively suppressed the HSV-1-induced mechanical allodynia (Fig. 6a) without any effect on the skin lesions (Fig. 6b). Here, NTRK2 is linked to neoplasm.